Mesoblast (MEOBF) Operating Leases (2019 - 2025)

Mesoblast (MEOBF) has disclosed Operating Leases for 7 consecutive years, with $6.3 million as the latest value for Q2 2025.

  • Quarterly Operating Leases rose 220.85% to $6.3 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Jun 2025, up 220.85% year-over-year, with the annual reading at $6.3 million for FY2025, 220.85% up from the prior year.
  • Operating Leases hit $6.3 million in Q2 2025 for Mesoblast, up from $2.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $8.5 million in Q2 2021 to a low of $2.0 million in Q2 2024.
  • Historically, Operating Leases has averaged $5.5 million across 5 years, with a median of $6.3 million in 2025.
  • Biggest five-year swings in Operating Leases: plummeted 48.17% in 2023 and later surged 220.85% in 2025.
  • Year by year, Operating Leases stood at $8.5 million in 2021, then fell by 16.5% to $7.1 million in 2022, then plummeted by 48.17% to $3.7 million in 2023, then crashed by 46.84% to $2.0 million in 2024, then soared by 220.85% to $6.3 million in 2025.
  • Business Quant data shows Operating Leases for MEOBF at $6.3 million in Q2 2025, $2.0 million in Q2 2024, and $3.7 million in Q2 2023.